Neogenomics Inc (NEO) returns
Neogenomics returns over 10 years
$1,000 invested in Neogenomics ten years ago was worth $2,159 at the close on October 30, 2026, with dividends reinvested: an average return of 8.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -5.3% | — | $946.62 | -0.9% |
| 3 months | +9.4% | — | $1,094 | +2.1% |
| Year to date | +47.8% | — | $1,478 | +11.7% |
| 1 year | +79.4% | — | $1,794 | +12.4% |
| 3 years | +27.7% | +8.5% | $1,277 | +88.5% |
| 5 years | -62.2% | -17.7% | $377.83 | +76.0% |
| 10 years | +115.9% | +8.0% | $2,159 | +316.6% |
Neogenomics return by calendar year
| Year | NEO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +47.8% | +11.7% | +36.1% |
| 2025 | -28.6% | +17.7% | -46.4% |
| 2024 | +1.9% | +24.9% | -23.0% |
| 2023 | +75.1% | +26.2% | +48.9% |
| 2022 | -72.9% | -18.2% | -54.7% |
| 2021 | -36.6% | +28.7% | -65.4% |
| 2020 | +84.1% | +18.4% | +65.7% |
| 2019 | +132.0% | +31.2% | +100.7% |
| 2018 | +42.3% | -4.6% | +46.9% |
| 2017 | +3.4% | +21.7% | -18.3% |
| 2016 | +8.9% | +12.0% | -3.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NEO financials
No forecast, no recommendation. This page describes Neogenomics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.